mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.06 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |